Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study

BACKGROUND: The study evaluated efficacy and safety of the 2 mg dose of prucalopride compared to placebo in patients with chronic constipation (CC) from the Asia-Pacific region. METHODS: Randomized, placebo-controlled, parallel-group, phase III study with 2-week run-in, 12-week treatment phase, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, M, Zou, D, Yuan, Y, Li, Y, Lin, L, Hao, J, Hou, X, Kim, HJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509366/
https://www.ncbi.nlm.nih.gov/pubmed/22882724
http://dx.doi.org/10.1111/j.1365-2982.2012.01983.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509366/
https://www.ncbi.nlm.nih.gov/pubmed/22882724
http://dx.doi.org/10.1111/j.1365-2982.2012.01983.x

Ejemplares similares